OpenLB
Open Library of Bioscience
Advanced Search

Journal Of Biopharmaceutical Statistics

Journal Information
Journal Abbr. J Biopharm Stat
Web of Sciences Category
Pharmacology & Pharmacy Statistics & Probability
Print ISSN 1054-3406
E-ISSN 1520-5711
NLM Catelog ID 9200436
Scopus Source ID 23035
Country UNITED STATES
Language English
Publisher Taylor & Francis Inc
Publisher Address 530 Walnut Street, Ste 850, Philadelphia, Usa, Pa, 19106

Related Publications

Found 2,148 results

Improving power in adaptive expansion of biomarker populations in phase 3 clinical trials.
Guoqing Diao, Xun Jiang, Donglin Zeng, May Mo, H Amy Xia, Joseph G Ibrahim
J Biopharm Stat. Mar 19, 2025.:1-12 Print-Electronic
Source:PubMed
PMID: 40108946 doi:10.1080/10543406.2025.2469871
Multi-arm multi-stage survival trial design with arm-specific stopping rule.
Jianrong Wu, Yimei Li, Liang Zhu, Tushar Patni
J Biopharm Stat. Sep 16, 2024.:1-12 Print-Electronic
Source:PubMed
PMID: 39282887 doi:10.1080/10543406.2024.2398036
Recurrent neural networks and attention scores for personalized prediction and interpretation of patient-reported outcomes.
Jinxiang Hu, Mohsen Nayebi Kerdabadi, Xiaohang Mei, Joseph Cappelleri, Richard Barohn, Zijun Yao
J Biopharm Stat. Mar 13, 2025.:1-11 Print-Electronic
Source:PubMed
PMID: 40079702 doi:10.1080/10543406.2025.2469884
Statistical considerations for using tolerance interval to set product specification for normally distributed attribute.
Chang Chen, Yi Tsong, Xutong Zhao, Meiyu Shen
J Biopharm Stat. Mar 13, 2025.:1-6 Print-Electronic
Source:PubMed
PMID: 40079049 doi:10.1080/10543406.2025.2473612
Efficient estimation of the cox model when incorporating the subgroup restricted mean survival time.
Jo-Ying Hung, Junjiang Zhong, Huang-Tz Ou, Pei-Fang Su
J Biopharm Stat. Mar 13, 2025.:1-22 Print-Electronic
Source:PubMed
PMID: 40079137 doi:10.1080/10543406.2024.2444242
Evaluation of inferential methods for the net benefit and win ratio statistics.
Johan Verbeeck, Brice Ozenne, William N Anderson
J Biopharm Stat. 09 02, 2020.30(5):765-782 Print-Electronic
Source:PubMed
PMID: 32097079 doi:10.1080/10543406.2020.1730873
A Bayesian framework for safety signal detection from medical device data.
Jianjin Xu, Adrijo Chakraborty, Archie Sachdeva, Ram Tiwari
J Biopharm Stat. Mar 10, 2025.:1-17 Print-Electronic
Source:PubMed
PMID: 40062556 doi:10.1080/10543406.2025.2464595
Dose-finding based on feasibility and late-onset toxicity in adoptive cell therapy trials.
Evan M Bagley, Nolan A Wages
J Biopharm Stat. 03, 2024.34(2):151-163 Print-Electronic
Source:PubMed
PMID: 36879525 doi:10.1080/10543406.2023.2183507
Assessing the incidence and severity of drug adverse events: a Bayesian hierarchical cumulative logit model.
Jiawei Duan, Byron J Gajewski, Paramita Sen, Jo A Wick
J Biopharm Stat. 03, 2024.34(2):276-295 Print-Electronic
Source:PubMed
PMID: 37016726 doi:10.1080/10543406.2023.2194385
Optimal dose selection in phase I/II dose finding trial with contextual bandits: a case study and practical recommendations.
Jixian Wang, Ram Tiwari
J Biopharm Stat. Feb 27, 2025.:1-27 Print-Electronic
Source:PubMed
PMID: 40017226 doi:10.1080/10543406.2025.2469877